Monday - Friday, 6:00 - 9:00 AM ET To future-proof your career in the age of AI, do 3 simple things: You'll 'remain valuable,' says expert United States Monday - Friday 6a ET Europe Monday - Friday 13 ...
EORTC 22961 is the latest trial to investigate the optimum duration of adjuvant androgen deprivation therapy for patients with locally advanced prostate cancer. The results conclusively show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results